Doma revenue improves in Q2; new business strategy unveiled | News

[ad_1]  FREE PREVIEW LOGIN OR SUBSCRIBE NOW TO READ THIS ARTICLE Industry News Thursday,…

BiondVax Reports Second Quarter Financial Results and Provides Business Update

[ad_1] JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) — via IBN – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for…